Description
FEBUMIZ-40 contains Febuxostat 40 mg, a xanthine oxidase inhibitor used to help manage elevated uric acid levels associated with gout and hyperuricaemia. By reducing the production of uric acid in the body, Febuxostat helps support the long-term management of uric acid levels.
The formulation is designed to provide consistent uric acid-lowering support as part of a physician-directed treatment plan. Maintaining appropriate uric acid levels may help in the overall management of gout and related complications associated with persistent hyperuricaemia.
FEBUMIZ-40 is available in a convenient tablet dosage form for oral administration. It should be taken strictly according to the dosage and duration recommended by a qualified healthcare professional.
This is a prescription medicine and should not be used without medical advice. The recommended dose and duration may vary according to the patient’s clinical condition and response to treatment.
Key Ingredients: Febuxostat 40 mg
Dosage Form: Tablets
Format: Uncoated Tablets
Pack Size: 10 × 1 × 15 Tablets
